Health Startup Fundraising

Raising capital in the health tech market
View as Markdown

Health tech fundraising is different from consumer or enterprise SaaS fundraising. Investors in health tech evaluate a broader set of risk factors — clinical, regulatory, reimbursement — alongside the standard team and market criteria.

The Health Tech Investor Landscape

Investor TypeFocusTypical Check Size
Angel investorsEarly-stage, domain expertise25K25K-500K
Health-specific VCsDigital health, therapeutics, devices2M2M-20M
Generalist VCsPlatform opportunities, larger rounds5M5M-50M+
Strategic investorsPharma, health systems, payersStrategic
Grants (SBIR/STTR)Early R&D, non-dilutive100K100K-2M

What Health Tech Investors Look For

Beyond standard startup metrics, health investors evaluate:

  • Clinical evidence: Do you have data supporting your approach?
  • Regulatory strategy: Clear pathway to clearance/approval
  • Reimbursement path: How will you get paid?
  • Go-to-market: B2B, B2C, or B2B2C? Who is the buyer?
  • Team: Health domain expertise + tech capability
  • Market timing: Regulatory tailwinds, policy changes

Pitch Deck Structure for Health Startups

A health startup pitch deck should include:

  1. Problem — Clinical and market need
  2. Solution — Product approach and innovation
  3. Clinical evidence — Existing data and validation plan
  4. Regulatory pathway — Clear timeline and strategy
  5. Market opportunity — TAM, SAM, SOM
  6. Business model — Who pays, how much, why
  7. Go-to-market — Sales strategy, partnerships
  8. Competition — Landscape positioning
  9. Team — Health + tech expertise

Non-Dilutive Funding

Grants can fund early-stage health tech development:

  • SBIR/STTR (US) : 100K100K-2M for R&D
  • Horizon Europe: EU research funding
  • NIH grants: Health-specific research programs
  • Innovate UK: UK health tech innovation funding